GlassScriptPhysician profile
Maria B Doyle
NPI 1700903820
$16,739.28
in general payments reported to CMS, 2019-2025
7 companies · $6,345 in 2025
The $6,345 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $34.26 · 2021: $1,690 · 2022: $206 · 2023: $30.48 · 2024: $7,566 · 2025: $6,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Honoraria: $3,200 · Consulting Fee: $2,800 · Travel and Lodging: $1,586 · Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Honoraria | $3,200.00 |
| Consulting Fee | $2,800.00 |
| Travel and Lodging | $1,585.73 |
| Food and Beverage | $355.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,999.43 | 2020-2025 | Da Vinci Surgical System |
| Organox LTD | $6,227.69 | 2024-2025 | Metra |
| Medtronic, INC. | $1,600.00 | 2021 | |
| Sirtex Medical INC | $750.00 | 2019 | |
| Olympus America INC. | $67.13 | 2019 | |
| Veloxis Pharmaceuticals, INC. | $50.00 | 2019 | |
| Ethicon US, LLC | $45.03 | 2022-2024 | Vistaseal, Surgicel Nu-Knit, Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.